Semaglutide

Semaglutide is a synthetic GLP-1 receptor agonist peptide designed to mimic the incretin hormone, promoting enhanced insulin secretion and glucose regulation. Widely studied for its efficacy in managing type 2 diabetes and obesity, this peptide supports appetite suppression and improved metabolic control. High purity and stability make it ideal for research and development applications.

Being studied for:

Management of type 2 diabetes mellitus

Obesity treatment and weight management

Reduction of cardiovascular risk in diabetic patients

Improvement of glycemic control and insulin sensitivity

Non-alcoholic steatohepatitis (NASH) and fatty liver disease

Neuroprotective effects in neurodegenerative disorders

Appetite suppression and energy balance regulation

Potential use in polycystic ovary syndrome (PCOS)

Adjunct therapy for metabolic syndrome